Medicago vaccine approved for people aged 18 to 64.
Health Canada has authorized the use of the first made-in Canada COVID-19 vaccine.
Medicago's two-dose plant-based vaccine has been approved for anyone aged 18 to 64.
Health Canada says the vaccine's effectiveness and safety for anyone outside of that age bracket has not been determined yet.
The dosing schedule is 21 days apart, and clinical trials suggest the vaccine was 71 percent effective in protecting against COVID-19 one week after the second dose.
The Quebec company submitted data to Health Canada in December.

Welland CAO Optimistic for 2026
Niagara Clinics Help Coughs, Colds
Clifton Hill Construction in January
Gas Prices to Hold Steady: Analyst
NRP Using Warrant in Niagara Falls Area
Part of Welland Canal Officially Named
Girl Assaulted in Break and Enter
Invest in Officer Well-Being: Former Chair